Bristol-Myers Squibb Company
BMY
$66.58
-$0.37-0.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.84% | 34.25% | 178.83% | 183.20% | 177.19% |
| Total Depreciation and Amortization | -49.26% | -54.57% | -57.42% | -51.82% | -35.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.98% | 83.20% | -74.70% | -72.60% | -72.47% |
| Change in Net Operating Assets | -282.52% | -12.63% | -156.17% | 536.25% | 209.74% |
| Cash from Operations | -19.62% | -7.02% | -6.81% | 10.78% | 12.27% |
| Capital Expenditure | -1.44% | -14.22% | -5.05% | -9.92% | -8.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -393.01% | -112.95% | 81.93% | 89.78% | 96.61% |
| Divestitures | -2.00% | 3.54% | -2.55% | 11.72% | 10.21% |
| Other Investing Activities | -122.36% | 260.98% | -91.59% | -952.17% | -188.65% |
| Cash from Investing | -253.64% | -68.56% | 80.65% | 87.25% | 93.89% |
| Total Debt Issued | 4,667.24% | 1,389.06% | -63.90% | -99.87% | -99.43% |
| Total Debt Repaid | -254.48% | -94.79% | -86.28% | 89.09% | 35.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.85% | -3.28% | -3.74% | -4.08% | -3.64% |
| Other Financing Activities | -33.68% | -9.82% | -20.75% | -31.03% | -48.44% |
| Cash from Financing | -40.68% | -3.85% | -301.83% | -177.06% | -229.48% |
| Foreign Exchange rate Adjustments | -145.97% | 411.54% | 242.34% | -51.14% | 559.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.58% | -183.84% | 88.99% | 2,310.15% | 396.62% |